Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT

Description

The primary goal of this project is to develop and test a Charcot Marie Tooth disease (CMT) Pediatric Scale for use in evaluation in natural history CMT study.

Conditions

Charcot Marie Tooth Disease

Talk to us

Study Overview

On this page

Study Details

Study overview

The primary goal of this project is to develop and test a Charcot Marie Tooth disease (CMT) Pediatric Scale for use in evaluation in natural history CMT study.

Development and Validation of CMT Pediatric Scale for Children With Charcot Marie Tooth

Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT

Condition
Charcot Marie Tooth Disease
Intervention / Treatment

-

Contacts and Locations

Palo Alto

Stanford University, Palo Alto, California, United States, 94305

Hartford

University of Connecticut/Connecticut Children's Medical Center, Hartford, Connecticut, United States, 06106

Orlando

Nemours Children's Clinic, Orlando, Florida, United States, 32827

Iowa City

University of Iowa, Iowa City, Iowa, United States, 52242

Ann Arbor

University of Michigan, Ann Arbor, Michigan, United States, 48109

Rochester

University of Rochester, Rochester, New York, United States, 14642

Philadelphia

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States, 19104

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Children (\< 21 years of age)
  • * Known or probable inherited neuropathies classified as CMT1, CMT2, or CMT4
  • * Known diagnoses of acquired neuropathy including toxic (e. g. medication related neuropathies); metabolic (e.g. diabetic), immune mediated or inflammatory \[acute inflammatory demyelinating polyradiculoneuropathy (AIDP) or chronic inflammatory demyelinating polyneuropathy (CIDP)\] polyneuropathies; neuropathy related to leukodystrophy, congenital muscular dystrophy; and patients with severe general medical conditions.
  • * Entirely normal conduction velocities of upper and lower limbs as this suggests that the subject may not have a neuropathy.

Ages Eligible for Study

to 21 Years

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Iowa,

Michael E Shy, MD, PRINCIPAL_INVESTIGATOR, University of Iowa

Study Record Dates

2024-12